A Risk Score to Predict Bleeding in Patients With Acute Coronary Syndromes

被引:571
作者
Mehran, Roxana [1 ,2 ]
Pocock, Stuart J. [3 ]
Nikolsky, Eugenia [1 ,2 ]
Clayton, Tim [3 ]
Dangas, George D. [1 ,2 ]
Kirtane, Ajay J. [1 ,2 ]
Parise, Helen [1 ,2 ]
Fahy, Martin [1 ,2 ]
Manoukian, Steven V. [4 ,5 ]
Feit, Frederick [6 ]
Ohman, Magnus E. [7 ]
Witzenbichler, Bernard [8 ]
Guagliumi, Giulio [9 ]
Lansky, Alexandra J. [1 ,2 ]
Stone, Gregg W. [1 ,2 ]
机构
[1] Columbia Univ, Med Ctr, New York, NY 10032 USA
[2] Cardiovasc Res Fdn, New York, NY USA
[3] London Sch Hyg & Trop Med, London WC1, England
[4] Sarah Cannon Res Inst, Nashville, TN USA
[5] Hosp Corp Amer, Nashville, TN USA
[6] NYU, Sch Med, New York, NY USA
[7] Duke Univ, Durham, NC USA
[8] Benjamin Franklin Univ Med Berlin, Berlin, Germany
[9] Osped Riuniti Bergamo, I-24100 Bergamo, Italy
关键词
bleeding; mortality; myocardial infarction; risk score; ACUTE MYOCARDIAL-INFARCTION; GLYCOPROTEIN IIB/IIIA INHIBITORS; STRATEGY ACUITY TRIAL; ACUTE CATHETERIZATION; CLINICAL-OUTCOMES; RANDOMIZED-TRIAL; GLOBAL REGISTRY; ISCHEMIC EVENTS; UNSTABLE ANGINA; ELUTING STENT;
D O I
10.1016/j.jacc.2009.09.076
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The aim of this study was to develop a practical risk score to predict the risk and implications of major bleeding in acute coronary syndromes (ACS). Background Hemorrhagic complications have been strongly linked with subsequent mortality in patients with ACS. Methods A total of 17,421 patients with ACS (including non-ST-segment elevation myocardial infarction [MI], ST-segment elevation MI, and biomarker negative ACS) were studied in the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) and the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) trials. An integer risk score for major bleeding within 30 days was developed from a multivariable logistic regression model. Results Non-coronary artery bypass graft surgery (CABG)-related major bleeding within 30 days occurred in 744 patients (7.3%) and had 6 independent baseline predictors (female sex, advanced age, elevated serum creatinine and white blood cell count, anemia, non-ST-segment elevation MI, or ST-segment elevation MI) and 1 treatment-related variable (use of heparin + a glycoprotein IIb/IIIa inhibitor rather than bivalirudin alone) (model c-statistic = 0.74). The integer risk score differentiated patients with a 30-day rate of non-CABG-related major bleeding ranging from 1% to over 40%. In a time-updated covariate-adjusted Cox proportional hazards regression model, major bleeding was an independent predictor of a 3.2-fold increase in mortality. The link to mortality risk was strongest for non-CABG-related Thrombolysis In Myocardial Infarction (TIMI)-defined major bleeding followed by non-TIMI major bleeding with or without blood transfusions, whereas isolated large hematomas and CABG-related bleeding were not significantly associated with subsequent mortality. Conclusions Patients with ACS have marked variation in their risk of major bleeding. A simple risk score based on 6 baseline measures plus anticoagulation regimen identifies patients at increased risk for non-CABG-related bleeding and subsequent 1-year mortality, for whom appropriate treatment strategies can be implemented. (J Am Coll Cardiol 2010;55:2556-66) (C) 2010 by the American College of Cardiology Foundation
引用
收藏
页码:2556 / 2566
页数:11
相关论文
共 45 条
[1]   Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes [J].
Alexander, KP ;
Chen, AY ;
Roe, MT ;
Newby, LK ;
Gibson, CM ;
Allen-LaPointe, NM ;
Pollack, C ;
Gibler, WB ;
Ohman, EM ;
Peterson, ED .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (24) :3108-3116
[2]   PRACTICAL PROBLEMS IN FITTING A PROPORTIONAL HAZARDS MODEL TO DATA WITH UPDATED MEASUREMENTS OF THE COVARIATES [J].
ALTMAN, DG ;
DESTAVOLA, BL .
STATISTICS IN MEDICINE, 1994, 13 (04) :301-341
[3]   Impact of age on management and outcome of acute coronary syndrome: Observations from the Global Registry of Acute Coronary Events (GRACE) [J].
Avezum, A ;
Makdisse, M ;
Spencer, F ;
Gore, JM ;
Fox, KAA ;
Montalescot, G ;
Eagle, KA ;
White, K ;
Mehta, RH ;
Knobel, E ;
Collet, JP .
AMERICAN HEART JOURNAL, 2005, 149 (01) :67-73
[4]   The relation of renal function to ischemic and bleeding outcomes with 2 different glycoprotein IIb/IIIa inhibitors: The Do Tirofiban and ReoPro Give Similar Efficacy Outcome (TARGET) trial [J].
Berger, PB ;
Best, PJM ;
Topol, EJ ;
White, J ;
DiBattiste, PM ;
Chan, AW ;
Kristensen, SD ;
Herrmann, HC ;
Moliterno, DJ .
AMERICAN HEART JOURNAL, 2005, 149 (05) :869-875
[5]  
Collet JP, 2008, CIRCULATION, V118, P1225, DOI [10.1161/CIRCULATIONAHA.108.776757, 10.1161/CIRCULATIONAHA.108.191108]
[6]   Major Femoral Bleeding Complications After Percutaneous Coronary Intervention Incidence, Predictors, and Impact on Long-Term Survival Among 17,901 Patients Treated at the Mayo Clinic From 1994 to 2005 [J].
Doyle, Brendan J. ;
Ting, Henry H. ;
Bell, Malcolm R. ;
Lennon, Ryan J. ;
Mathew, Verghese ;
Singh, Mandeep ;
Holmes, David R. ;
Rihal, Charanjit S. .
JACC-CARDIOVASCULAR INTERVENTIONS, 2008, 1 (02) :202-209
[7]   Outcomes Following Pre-Operative Clopidogrel Administration in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery The ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial [J].
Ebrahimi, Ramin ;
Dyke, Cornelius ;
Mehran, Roxana ;
Manoukian, Steven V. ;
Feit, Frederick ;
Cox, David A. ;
Gersh, Bernard J. ;
Ohman, E. Magnus ;
White, Harvey D. ;
Moses, Jeffrey W. ;
Ware, James H. ;
Lincoff, A. Michael ;
Stone, Gregg W. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (21) :1965-1972
[8]   Adverse impact of bleeding on prognosis in patients with acute coronary syndromes [J].
Eikelboom, John W. ;
Mehta, Shamir R. ;
Anand, Sonia S. ;
Xie, Changchun ;
Fox, Keith A. A. ;
Yusuf, Salim .
CIRCULATION, 2006, 114 (08) :774-782
[9]   Predictors and impact of major Hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 trial [J].
Feit, Frederick ;
Voeltz, Michele D. ;
Attubato, Michael J. ;
Lincoff, A. Michael ;
Chew, Derek P. ;
Bittl, John A. ;
Topol, Eric J. ;
Manoukian, Steven V. .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (09) :1364-1369
[10]   Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical Revascularization for non-ST-elevation acute coronary syndrome - The Clopidogrel in Unstable Angina to prevent Recurrent Ischemic Events (CURE) trial [J].
Fox, KAA ;
Mehta, SR ;
Peters, R ;
Zhao, F ;
Lakkis, N ;
Gersh, BJ ;
Yusuf, S .
CIRCULATION, 2004, 110 (10) :1202-1208